Industry News


Industry News
Global Trends
Events Calendar
Web Links

Web Gallery

Advertising  Info



Johnson & Johnson Expects Growth In Hip Replacement Products, Medical Devices Through 2012

Diversified health care products company Johnson & Johnson expects sharp growth from its medical device units over the next several years, with orthopedic and surgical care products leading the way.

The company expects an average of 6 percent annual growth in revenue from the surgical care unit over the next 4 years, reaching $40 billion in 2012. Orthopedic products, many of which are used to fix damaged or diseased joints, will get a 9 percent annual boost to $48 billion, according to projections.

Sheri McCoy, worldwide chairwoman for the surgical care unit, said the company is focusing on developing less-invasive surgical products and looking to emerging markets to help fuel growth. More than half of surgical sales now come from outside the U.S., she said.

Michael Mahoney, the group chairman of Depuy, which makes spine, hip and knee products, said the unit gets more than 40 percent of its revenue from outside the U.S. and claims the No. 2 spot in the global market, while retaining the top spot in the U.S. market.

Brazil, Russia, India, and China had record growth last year, and the company is making investments to build on that momentum.

The company has been introducing a range of new product platforms that include more durable materials and instruments for minimally invasive surgery. Those are both necessary to stay on top, as patients in several segments are increasingly younger, including hip replacement patients, who are demanding better implants and less-invasive techniques.

The Depuy unit was the largest revenue contributor out of the medical device division, accounting for $4.59 billion in sales in 2007. Overall, medical device sales are the second largest revenue driver for the company, behind pharmaceutical sales.


Solvay Advanced Polymers Commissions New PEEK Plant In India

Solvay Advanced Polymers, makers of more plastics with more performance has announced that it has commissioned its new commercial PEEK (polyetheretherketone) facility at its site in Panoli, India. The new facility is now in its start-up phase and is running initial commercial production. The plant is capable of producing 500 metric tons annually, and is scalable in design to double capacity to meet demand for Solvay Advanced Polymers’ KetaSpire® PEEK and AvaSpire® modified PEEK products.

With this the company has completed a significant step in its strategic entrance into the PEEK market. In the past 18 months, Solvay Advanced Polymers has been seeding and specifying its KetaSpire PEEK and AvaSpire modified PEEK into a range of markets and applications from its semi-commercial facility. The new commercial facility in Panoli will now support and expand upon those opportunities.

KetaSpire PEEK and AvaSpire modified PEEK are highly-prized ultra polymers that offer design engineers best-in-class chemical resistance and mechanical properties, including strength, stiffness and ease of processing. This combination of performance attributes makes PEEK an ideal polymer for applications in aerospace, automotive, friction and wear components, healthcare, oil exploration and production, and semi-conductors, among others. KetaSpire PEEK is also available in film form for specialized applications.



Other News

Trivitron JVs with intl cos. to set up India's first Medical Technology Park (MTP)
Medical Devices Made with Tainted Heparin Recalled by Medtronic
Italy-India forum focuses on technology co-operation
Global medical nonwoven disposables market to reach $12 billion by 2010
German firm invests Rs 110 cr in India
Biocon Launches Pre-Filled Safety Syringe
Siemens To Install India's 1st Magnetom Essenza At Aatmajyoti MRI Center
DES From Abbott Outperforms Market-Leading Stent
FDA Claims To Approve Medical Devices Faster
Essel Propack: Acquisition In Medical Devices
Medical Devices, The Next Big Step For Semiconductor Makers





Back | Back To Top | Previous | Next